Skip to main content
SpringerLink
Log in

Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. doi:10.1245/s10434-010-1154-5.

  2. Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006;17:1733–42.

    Article  PubMed  CAS  Google Scholar 

  3. Arnold R, Rinke A, Schmidt C, Hofbauer L. Endocrine tumours of the gastrointestinal tract: chemotherapy. Best Pract Res Clin Gastroenterol. 2005;19:649–56.

    Article  PubMed  CAS  Google Scholar 

  4. Kwekkeboom DJ, de Herder WW, Kam BL, et al. Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol. 2008;26(13):2124–30.

    Article  PubMed  CAS  Google Scholar 

  5. Saxena A, Chua TC, Bester L, et al. Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases. Ann Surg. 2010;251:901–6.

    Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Hepatobiliary and Surgical Oncology Unit, Department of Surgery, St George Hospital, University of New South Wales, Kogarah, Sydney, NSW, Australia

    Akshat Saxena BMedSc, Terence C. Chua BScMed (Hons), MBBS & David L. Morris MD, PhD, FRCS, FRACS

Authors
  1. Akshat Saxena BMedSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terence C. Chua BScMed (Hons), MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David L. Morris MD, PhD, FRCS, FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David L. Morris MD, PhD, FRCS, FRACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saxena, A., Chua, T.C. & Morris, D.L. Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer. Ann Surg Oncol 18 (Suppl 3), 222–223 (2011). https://doi.org/10.1245/s10434-010-1342-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1342-3

Keywords

Search

Navigation